MNTS.NASDAQMomentus INC

DEF 14A: Momentus Inc. Seeks Stockholder Approval for Warrant Repricing and Director Elections at 2024 Annual Meeting

Sentiment:

Proxy Statement


Momentus Inc. is holding its 2024 Annual Meeting of Stockholders on June 28, 2024, to vote on director elections, ratification of the independent accounting firm, and a warrant repricing proposal.

Capital raiseThe company is seeking to reprice certain existing warrants of the Company (the Warrant Repricing Proposal).As previously disclosed, on March 7, 2024, we closed a transaction with an institutional investor as the purchaser (the Investor) in which we sold, and the Investor purchased, in a registered direct offering (i) an aggregate of 1,320,000 shares of the Companys Class A common stock, at a purchase price of $0.865 per share of Class A common stock and one March 2024 Warrant (as defined below), (ii) in lieu of Class A common stock, at the election of the Investor, pre-funded warrants to purchase 3,304,280 shares of Class A common stock, at a purchase price of $0.86499 per pre-funded warrant, and (iii) warrants to purchase 4,624,280 shares of Class A common stock (the March 2024 Warrants), pursuant to the terms of a Securities Purchase Agreement (the Securities Purchase Agreement) that we entered into with the Investor.Additionally, the Securities Purchase Agreement provides for a warrant repricing transaction (the Warrant Repricing Transaction) with respect to warrants to purchase up to 3,687,000 shares of the Companys Class A common stock initially issued by the Company to the Investor on January 17, 2024 (the January 2024 Warrants).

Summary

  • Momentus Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 28, 2024.
  • Stockholders of record as of May 17, 2024, are eligible to vote.
  • The meeting will address the election of four directors, ratification of Frank, Rimerman + Co. LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and approval of the Warrant Repricing Proposal.
  • The Board of Directors recommends voting FOR all director nominees, FOR the ratification of the accounting firm, and FOR the Warrant Repricing Proposal.
  • A total of 16,625,904 shares of common stock were outstanding on the record date and are entitled to be voted.
  • The Warrant Repricing Proposal seeks to reprice certain existing warrants, with a potential reduction of the exercise price from $0.96 to $0.74 per share and an extension of the termination date.
  • If Stockholder Approval is not obtained by July 17, 2024, then automatically and without any approval of stockholders (i) the exercise price of the January 2024 Warrants will be reduced (if and only if such new exercise price on the repricing date is lower than the exercise price of the January 2024 Warrants then in effect) to be the Minimum Price (as defined below) of the Class A Stock on July 17, 2024, and (ii) the termination date of the January 2024 Warrants will be extended to January 17, 2029.

Sentiment

Score: 6

Explanation: The document is primarily informational, outlining the agenda and proposals for the annual meeting. The sentiment is neutral, with a slight positive leaning due to the board's recommendations and efforts to align interests with shareholders.

Positives

  • The Board is actively engaged in corporate governance, with regular meetings and committees overseeing key areas.
  • The company has stock ownership guidelines to align the interests of directors and executive officers with those of shareholders.
  • The Audit Committee actively oversees the independent auditor's performance and independence.
  • The proposed warrant repricing could potentially benefit the company by encouraging warrant exercises and increasing capital.

Negatives

  • The company was unable to hold its Annual Meeting of Stockholders in 2023.
  • The company previously solicited stockholder approval in connection with a similar warrant repricing transaction with respect to warrants to purchase up to 5,808,538 shares of the Companys Class A common stock initially issued by the Company to the Investor on November 9, 2023 (the November 2023 Warrants).
  • The Company called to order a special meeting of stockholders on March 15, 2024 (the March Special Meeting) to hold a vote on the repricing transaction of the November 2023 Warrants, however there were not present or represented by proxy a sufficient number of shares of the Companys common stock in order to constitute a quorum at the March Special Meeting.

Risks

  • Failure to obtain stockholder approval for the Warrant Repricing Proposal could lead to automatic adjustments to the warrant terms.
  • The company operates in a highly regulated industry, and compliance with regulations is critical.
  • The company is subject to risks associated with being an emerging growth company and a smaller reporting company, including potential limitations on disclosure and reporting requirements.
  • The company's success depends on attracting and retaining qualified personnel.

Future Outlook

The company is seeking stockholder approval for key proposals that will impact its governance and financial structure.

Management Comments

  • The Board of Directors believes that it is in the best interests of the Company and its shareholders that directors and executive officers have a meaningful proprietary stake in the Company so that their interests are aligned with the interests of shareholders.
  • The Board of Directors recommends a vote FOR the election of each of the director nominees.
  • The Board of Directors unanimously recommends that stockholders vote FOR the ratification of the selection of Frank, Rimerman + Co. LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.
  • THE BOARD RECOMMENDS THAT YOU VOTE FOR THE WARRANT REPRICING PROPOSAL.

Industry Context

The company operates in the space industry, which is characterized by rapid technological advancements and increasing competition.

Comparison to Industry Standards

  • The document does not contain specific comparisons to industry standards.
  • Director compensation policies are generally designed to be competitive with those of similar-sized companies in the same industry.
  • The selection and oversight of an independent accounting firm are standard practices for publicly traded companies.

Related Party Transactions

  • The document mentions indemnification agreements with directors and executive officers.
  • The document mentions a related party transactions policy requiring Audit Committee approval for transactions exceeding $120,000.

Stakeholder Impact

  • The outcome of the proposals will directly impact shareholders through potential changes in the company's governance and capital structure.
  • The election of directors will shape the company's strategic direction and oversight.
  • The ratification of the accounting firm ensures the integrity of the company's financial reporting.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold the Annual Meeting of Stockholders on June 28, 2024.
  • The company will file a Form 8-K to report the final voting results of the Annual Meeting.

Key Dates

DateDescription
January 17, 2024Date of initial issuance of the January 2024 Warrants.
March 7, 2024Date of closing of transaction with institutional investor.
May 9, 2024Record date for determining stockholders eligible to vote at the Annual Meeting.
June 5, 2024Original deadline for holding a meeting of stockholders to request approval of the Warrant Repricing Transaction.
June 6, 2024Anticipated date of mailing the Notice Regarding the Availability of Proxy Materials.
June 27, 2024Deadline for voting online, by phone, or by mail.
June 28, 2024Date of the Annual Meeting of Stockholders.
July 17, 2024Deadline for obtaining Stockholder Approval for the Warrant Repricing Transaction.
February 6, 2025Deadline for stockholders to submit proposals for inclusion in the 2025 proxy statement.
February 28, 2025Earliest date for stockholders to submit director nominations or other proposals for the 2025 annual meeting without inclusion in the proxy statement.
March 30, 2025Latest date for stockholders to submit director nominations or other proposals for the 2025 annual meeting without inclusion in the proxy statement.

Keywords

proxy statement, annual meeting, stockholders, directors, warrant repricing, corporate governance, Momentus Inc., election, ratification, accounting firm

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.